Assessment of Intracerebral Hematoma

Not Applicable

• Conditions: Intracerebral Hematoma
• Interventions: Device: transcranial duplex sonography

• Registration Number: NCT05158660
• Lead Sponsor: Assiut University

Brief Summary

The study will assess acute intracerebral hematoma expansion within the first 48 hours from the onset using transcranial duplex sonography in patients who have acute intracerebral hematoma , and will also assess the correlation between the transcranial duplex sonography measurements and the clinical outcome of these patients .

Detailed Description

Not available

Study Timeline

• Status Verified: 2021-12
• Study First Submitted: 2021-12-03
• Study First Submitted QC: 2021-12-03
• Last Update Submitted: 2021-12-03
• Study First Posted: 2021-12-15
• Last Update Posted: 2021-12-15
• Study Start: 2022-01
• Primary Completion: 2022-10
• Study Completion: 2023-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

1. first ever non traumatic supratentorial primary intracerebral haemorrhage on non contrast CT brain
2. admitted within 24 hours of symptom onset

Exclusion Criteria

1. blood diseases, decompansated hepatic or renal impairment, or encephalopathy caused by electrolyte disturbance
2. on anticoagulant treatment
3. if devolped major complications during hospitalization ( e.g sever chest infection, hypoxia, or deep venous thrombosis )
4. comorbid neurological or psychiatric disorders

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
patients assessed by transcranial duplex sonography	transcranial duplex sonography	-

Primary Outcome Measures

Name	Time	Method
change from baseline in volume of intracerebral hematoma	at baseline, then 24 hour after the baseline, and finally 48 hours after the baseline